Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
Frontiers in Cellular and Infection Microbiology · 28.11.2024 · 14
DOI: 10.3389/fcimb.2024.1451539 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.11.2024. Verfasst von Zhuo-Yun Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Antigens, Fungal, Cryptococcosis, Luminescent Measurements, Sensitivity and Specificity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to assess the efficacy of innovative Chemiluminescence Immunoassay (CLIA) in testing Cryptococcal Antigen (CrAg) across two medical centers, employing the FDA-approved CrAg Lateral Flow Assay (LFA) by IMMY as a reference standard.
Methods
The study encompassed patients diagnosed with cryptococcosis at West China Hospital of Sichuan University (HX) between July 2022 and May 2023, and Suzhou Fifth People’s Hospital (SZ) from September 2020 to September 2023. All specimens underwent simultaneous detection using the LFA (IMMY, Norman, USA) and CLIA (Chuanglan, Suzhou, China).
Results
A total of 628 patients were enrolled, revealing a remarkable 99.20% concordance between LFA and CLIA (623/628, 99.20%). The LFA exhibited a sensitivity of 96.83% (244/252) and specificity of 98.35% (179/182). Among the 42 patients with unaltered CrAg titers, the changes of Signal-to-Cut-Off ratio (ΔS/CO) results exhibited a noteworthy discrepancy, with 71.43% (30/42) demonstrating a decreasing trend in ΔS/CO of at least 10%.
Conclusions
The CLIA method demonstrated commendable specificity and sensitivity, exhibiting a high level of agreement with the FDA-approved LFA method. Additionally, CLIA demonstrated superior utility for treatment monitoring compared to LFA, offering continuous insight into the fluctuation of CrAg concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Clinical Laboratory, The Fifth People's Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, Suzhou, Jiangsu, China.
Zitieren
APA
Tang, Z. Y., Xu, P., Wang, Z. H., Wang, T. T., Zhou, D., Ao, K. P., Song, H. F., Yin, X. Y., & Li, D. D. (2024). Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1451539
Vancouver
Tang ZY, Xu P, Wang ZH, Wang TT, Zhou D, Ao KP, et al. Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1451539
BibTeX
@article{Tang2024,
author = {Tang, Zhuo-Yun and Xu, Ping and Wang, Zhong-Hao and Wang, Ting-Ting and Zhou, Dan and Ao, Ke-Ping and Song, Hua-Feng and Yin, Xiao-Yun and Li, Dong-Dong},
title = {Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1451539}
}
EUVIMED